Rapid Cycling Bipolar Disorder: Phenomenology and Treatment

Joseph F. Goldberg; Michael Berk

doi:10.1002/9780470661277.ch25

Rapid Cycling Bipolar Disorder: Phenomenology and Treatment

Joseph F. Goldberg, Michael Berk

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Original language	English
Title of host publication	Bipolar Disorder
Subtitle of host publication	Clinical and Neurobiological Foundations
Publisher	John Wiley and Sons
Pages	333-341
Number of pages	9
ISBN (Print)	9780470721988
DOIs	https://doi.org/10.1002/9780470661277.ch25
State	Published - 13 Aug 2010

Keywords

Anti-cycling agents, both the safest and most effective biological therapies - for rapid cycling
Antidepressants and rapid cycling
Carbamazepine for bipolar mania - conducted by Okuma and colleagues in Japan
Cycle length reduction, an accepted metric of impact of therapy on cycle change
L-type dihydropyridine calcium channel blocker and anticonvulsant nimodipine - reduction in cycling frequency in bipolar disorder patients
Rapid cycling bipolar disorder
Rapid cycling bipolar disorder - phenomenology and treatment
Rapid cycling, common in women - linking reproductive health and menstrual cycle, not fully demonstrated
Suprametabolic doses of thyroid hormone - for treatment of refractory rapid cycling
Two-year open-label trial of chromium - reported in rapid cycling individuals

Access to Document

10.1002/9780470661277.ch25

Cite this

@inbook{fe81a4b6b6a94cbea1560dd419758107,

title = "Rapid Cycling Bipolar Disorder: Phenomenology and Treatment",

keywords = "Anti-cycling agents, both the safest and most effective biological therapies - for rapid cycling, Antidepressants and rapid cycling, Carbamazepine for bipolar mania - conducted by Okuma and colleagues in Japan, Cycle length reduction, an accepted metric of impact of therapy on cycle change, L-type dihydropyridine calcium channel blocker and anticonvulsant nimodipine - reduction in cycling frequency in bipolar disorder patients, Rapid cycling bipolar disorder, Rapid cycling bipolar disorder - phenomenology and treatment, Rapid cycling, common in women - linking reproductive health and menstrual cycle, not fully demonstrated, Suprametabolic doses of thyroid hormone - for treatment of refractory rapid cycling, Two-year open-label trial of chromium - reported in rapid cycling individuals",

author = "Goldberg, {Joseph F.} and Michael Berk",

year = "2010",

month = aug,

day = "13",

doi = "10.1002/9780470661277.ch25",

language = "English",

isbn = "9780470721988",

pages = "333--341",

booktitle = "Bipolar Disorder",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Rapid Cycling Bipolar Disorder

T2 - Phenomenology and Treatment

AU - Goldberg, Joseph F.

AU - Berk, Michael

PY - 2010/8/13

Y1 - 2010/8/13

KW - Anti-cycling agents, both the safest and most effective biological therapies - for rapid cycling

KW - Antidepressants and rapid cycling

KW - Carbamazepine for bipolar mania - conducted by Okuma and colleagues in Japan

KW - Cycle length reduction, an accepted metric of impact of therapy on cycle change

KW - L-type dihydropyridine calcium channel blocker and anticonvulsant nimodipine - reduction in cycling frequency in bipolar disorder patients

KW - Rapid cycling bipolar disorder

KW - Rapid cycling bipolar disorder - phenomenology and treatment

KW - Rapid cycling, common in women - linking reproductive health and menstrual cycle, not fully demonstrated

KW - Suprametabolic doses of thyroid hormone - for treatment of refractory rapid cycling

KW - Two-year open-label trial of chromium - reported in rapid cycling individuals

UR - http://www.scopus.com/inward/record.url?scp=84885999749&partnerID=8YFLogxK

U2 - 10.1002/9780470661277.ch25

DO - 10.1002/9780470661277.ch25

M3 - Chapter

AN - SCOPUS:84885999749

SN - 9780470721988

SP - 333

EP - 341

BT - Bipolar Disorder

PB - John Wiley and Sons

ER -